Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Belgium / NCT02071134
Recruiting Observational

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

NCT02071134 · tracked via the Priya Life Science Belgium tracker
Sponsor
Boston Scientific Corporation
Phase
Observational
Started
2014-03-04
Last updated
2026-09-16

Condition(s) studied

Parkinson's Disease

Investigational drug(s) / intervention(s)

Deep Brain Stimulation (DBS)

Deep Brain Stimulation (DBS): Subjects receiving Deep Brain Stimulation (DBS) for the treatment of their Parkinson's disease symptoms will be offered participation in this registry.

Study summary

The purpose of this registry is to compile characteristics of world-wide outcomes for the use of Boston Scientific's commercially available Vercise DBS System in the treatment of Parkinson's disease.

The utilization of Image Guided Programming (IGP), and other commercially available programming features, used as planning tools for the programming of patients with Boston Scientific's Vercise DBS System are also evaluated.

Additionally, the utilization of the DBS Illumina 3D feature that may be used for the programming of patients with Boston Scientific's Vercise DBS Systems is also evaluated.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Key Inclusion Criteria: * Meets criteria established in locally applicable Vercise System Direction for Use * At least 18 years old Key Exclusion Criteria: * Meets any contraindication in the Vercise System locally applicable Directions for Use Subjects with significant cognitive or psychiatric impairment may be excluded in the evaluation of GXT.

Primary outcome measure(s)

Trial sites (86)

FacilityCityRegionStatus
Neurology and Pain Specialty Aliso Viejo California Withdrawn
Cedars Sinai Medical Center Los Angeles California Recruiting
University of Colorado Aurora Colorado Recruiting
St. Mary's Hospital and Medical Center Grand Junction Colorado Recruiting
University of Florida Shands Hospital Gainesville Florida Recruiting
Mayo Clinic, Jacksonville Jacksonville Florida Withdrawn
University of Miami Hospital Miami Florida Recruiting
Tallahassee Neurological Clinic, PA Tallahassee Florida Withdrawn
University of South Florida Tampa Florida Recruiting
St. Luke Regional Medical Center Boise Idaho Recruiting
Rush University Medical Center Chicago Illinois Recruiting
Methodist Hospital of Indianapolis Indianapolis Indiana Completed
Massachusetts General Hospital Boston Massachusetts Withdrawn
St. Louis University Hospital St Louis Missouri Withdrawn
Albany Medical College Albany New York Completed
Northwell Health Neuroscience Institute Great Neck New York Recruiting
University at Buffalo Williamsville New York Recruiting
Wake Forest University School of Medicine Winston-Salem North Carolina Recruiting
Cleveland Clinic Foundation Cleveland Ohio Terminated
Ohio State University Columbus Ohio Recruiting
Vanderbilt University Nashville Tennessee Withdrawn
Houston Methodist Research Institute Houston Texas Recruiting
University of Texas Health Medical Arts and Research Center San Antonio Texas Recruiting
Texas Institute for Neurological Disorders Sherman Texas Recruiting
University of Virginia Medical Center Charlottesville Virginia Withdrawn
Evergreen Health Kirkland Washington Recruiting
Virginia Mason Medical Center Seattle Washington Recruiting
University of Washington Medical Center Seattle Washington Recruiting
Inland Northwest Research Spokane Washington Recruiting
Fundacion Ineco-Research Facility Buenos Aires Argentina Recruiting
A.o. LKH Univ.-Kliniken Innsbruck Innsbruck Austria Recruiting
AZ Sint-Lucas Ghent Belgium Active Not Recruiting
UZ Gasthuisberg Leuven Belgium Active Not Recruiting
AZ Delta Roeselare Belgium Active Not Recruiting
Queen Elizabeth II Health Sciences Center Halifax Canada Active Not Recruiting
Hopital de Enfant-Jesus Québec Canada Active Not Recruiting
CHU Henri Mondor Créteil France Active Not Recruiting
Hopital Neurologique Pierre Wertheimer Lyon France Completed
CHU La Timone Hospital Marseille France Active Not Recruiting
Fondation Ophtalmologique Adolphe de Rothschild Paris France Terminated

+ 46 more sites — see the full list on the official registry below.

More Boston Scientific Corporation trials in Belgium

BoStOn SCientific Rhythm MAnagemenT REgiStry Recruiting
Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET) Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain Recruiting

Other trials for the same condition

Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Active, not recruiting
A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa/Foscarbidopa in Belgium Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02071134 on ClinicalTrials.gov ↗ ← All trials in Belgium